Eric Lefebvre - 23 Jan 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Chief Medical Officer
Signature
/s/ Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
23 Jan 2023
Transactions value $
-$2,327,630
Form type
4
Filing time
25 Jan 2023, 20:00:38 UTC
Previous filing
21 Dec 2022
Next filing
27 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Sale -$2.33M -67.5K -46.74% $34.48 76.9K 23 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.